Regel Therapeutics
About:
Regel Therapeutics provides gene therapy that significantly improve the lives of people with life-threatening genetic illnesses.
Website: https://regeltherapeutics.com/
Top Investors: HS Chau Foundation
Description:
Regel Therapeutics is dedicated to revolutionizing gene therapy and transforming patient outcomes across a variety of indications by utilizing its unique platform technology.
Total Funding Amount:
$1M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Boston, Massachusetts, United States
Founded Date:
2020-01-01
Contact Email:
info(AT)regeltherapeutics.com
Founders:
Number of Employees:
11-50
Last Funding Date:
2023-09-29
IPO Status:
Private
Industries:
© 2025 bioDAO.ai